Outlook Therapeutics (OTLK) Cash from Financing Activities (2015 - 2026)
Outlook Therapeutics' Cash from Financing Activities was $26.6 million in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 100.9% from $13.25 million a year earlier and up 285.6% from the prior quarter.
Outlook Therapeutics (OTLK) Cash from Financing Activities (2015 - 2026) Analysis & Trends
On a trailing twelve-month basis, Outlook Therapeutics' Cash from Financing Activities was $60.6 million through Jun 30, 2026, up 81.9% year-over-year; for FY2025 (ended Sep 30, 2025), it was $44.98 million, down 25.4% from FY2024.
- Cash from Financing Activities shows a five-year compound annual growth rate of 3.9% (FY2020 to FY2025).
- In earlier fiscal years, Cash from Financing Activities was $60.33 million in FY2024 (+23.2%), $48.97 million in FY2023 (-17.8%), $59.59 million in FY2022 (+6.0%) and $56.19 million in FY2021 (+51.0%).
- The fiscal Q3 2026 figure marks the highest quarterly Cash from Financing Activities since fiscal Q2 2024.
- Compared with a year earlier, Cash from Financing Activities was higher in three of the last five quarters, with growth averaging 194.0%.
- The best year-over-year quarter for Cash from Financing Activities over five years was fiscal Q1 2022 (growth of 948.6%); the worst was fiscal Q2 2022 (a decline of 94.0%).
- Per Business Quant data, OTLK's Cash from Financing Activities in the three fiscal quarters before Q3 2026 was $6.9 million (Q2 2026), $15.53 million (Q1 2026) and $11.56 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | -8.78 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.05 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 1.76 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -2.02 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -47.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -1.48 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 2.34 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -3.66 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | -426.70 Mn |
| 10 | Outlook Therapeutics | 77.94 Mn | 42.19 Mn | -8,265.00 | 26.60 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 26.60 Mn |
| Mar 31, 2026 | 6.90 Mn |
| Dec 31, 2025 | 15.53 Mn |
| Sep 30, 2025 | 11.56 Mn |
| Jun 30, 2025 | 13.25 Mn |
| Mar 31, 2025 | 18.44 Mn |
| Dec 31, 2024 | 1.74 Mn |
| Sep 30, 2024 | -114,954.00 |
| Jun 30, 2024 | 4.31 Mn |
| Mar 31, 2024 | 56.14 Mn |
| Dec 31, 2023 | -3,183.00 |
| Sep 30, 2023 | 2.42 Mn |
| Jun 30, 2023 | 3.30 Mn |
| Mar 31, 2023 | -597,128.00 |
| Dec 31, 2022 | 43.85 Mn |
| Sep 30, 2022 | 1.63 Mn |
| Jun 30, 2022 | -11.30 Mn |
| Mar 31, 2022 | 2.61 Mn |
| Dec 31, 2021 | 66.66 Mn |
| Sep 30, 2021 | 3.78 Mn |
Outlook Therapeutics Cash from Financing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OTLK&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-financing-activities", "ticker": "OTLK", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=OTLK&period=max&api_key=YOUR_API_KEY");
const data = await res.json();